8 min read
Monthly FDA Guidance and Regulatory News Review - July 2026
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...
Meet Veristat in Boston at the Fierce Biotech Summit Conference | September 30 - October 1 in Boston, Massachusetts
We are delighted to announce Veristat's participation in the upcoming Fierce Biotech Summit. This is an excellent opportunity to connect with our team of seasoned experts in clinical development, regulatory affairs, and biometrics. Our professionals are dedicated to guiding your innovative therapies through the complex landscape of drug development and regulatory approval.
Veristat supports successful clinical trials and regulatory submissions across a wide range of therapeutic areas, including rare diseases, oncology, and complex clinical development programs. Our expertise spans:
- Strategic clinical trial design and execution
- Comprehensive regulatory strategy and submissions
- Advanced biostatistics and data management
- Medical writing and regulatory publishing
Overcome the challenges of drug development with confidence. Let Veristat's proven track record of 160+ marketing applications and 80+ regulatory approvals work for you. Connect with us at the Fierce Biotech Summit to learn how we can accelerate your path to approval and bring your innovations to patients faster.
Schedule A Meeting
Veristat team member, Erin Gaffney, Senior Business Development Director, will be at the venue, ready to listen to your needs and share more about Veristat’s expertise. Arrange a meeting today! Complete the form on the right side of this page and we will confirm the date and time.
Conference Details
Website: Fierce Biotech Summit
Schedule A Meeting
Meet with us at the Fierce Biotech Summit 2024 by filling out the form below.
Event Topics:
1 min read
Scope of Things Podcast: Daphne Smyth on the Chinese Drug Development Market Expansion
Aug 12, 2026 Veristat Blog
China is rapidly becoming one of the most influential forces in global drug development—but bringing innovative...